Design of a series of bicyclic HIV-1 integrase inhibitors. Part 1: Selection of the scaffold

被引：36

作者：

Jones, Eric D. ^{[1
]}

Vandegraaff, Nick ^{[1
]}

Le, Giang ^{[1
]}

Choi, Neil ^{[1
]}

Issa, William ^{[1
]}

Macfarlane, Katherine ^{[1
]}

Thienthong, Neeranat ^{[1
]}

Winfield, Lisa J. ^{[1
]}

Coates, Jonathan A. V. ^{[1
]}

Lu, Long ^{[2
]}

Li, Xinming ^{[2
]}

Feng, Xiao ^{[2
]}

Yu, Changjiang ^{[2
]}

Rhodes, David I. ^{[1
]}

Deadman, John J. ^{[1
]}

机构：

[1] Avexa Ltd, Richmond, Vic 3121, Australia

[2] Chinese Acad Sci, Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 19期

关键词：

Integrase; Inhibitor; Synthesis; 3-Hydroxy-pyrido[12-a]pyrimidin-4-one;

D O I：

10.1016/j.bmcl.2010.07.079

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

HIV integrase inhibitors based on a novel bicyclic pyrimidinone core is presented. Nine variations of the core scaffold are evaluated leading to optimization of the 6:6 core giving compound 48 with an EC50 of 3 nM against wild type HIV infected T-cells. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：5913 / 5917

页数：5

共 50 条

[21] Thiazolothiazepine inhibitors of HIV-1 integrase
Neamati, N
Turpin, JA
Winslow, HE
Christensen, JL
Williamson, K
Orr, A
Rice, WG
Pommier, Y
Garofalo, A
Brizzi, A
Campiani, G
Fiorini, I
Nacci, V
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (17) : 3334 - 3341
[22] Authentic HIV-1 integrase inhibitors
Liao, Chenzhong
Marchand, Christophe
Burke, Terrence R., Jr.
Pommier, Yves
Nicklaus, Marc C.
FUTURE MEDICINAL CHEMISTRY, 2010, 2 (07) : 1107 - 1122
[23] De novo design and synthesis of HIV-1 integrase inhibitors
Makhija, MT
Kasliwal, RT
Kulkarni, VM
Neamati, N
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (09) : 2317 - 2333
[24] Use of a Hexasubstituted Benzene Scaffold in the Development of Multivalent HIV-1 Integrase Inhibitors
Tupehiangmai, Wipa
Choksakulporn, Saowanaporn
Tewtrakul, Supinya
Pianwanit, Somsak
Sritana-anant, Yongsak
CHEMICAL & PHARMACEUTICAL BULLETIN, 2014, 62 (08) : 754 - 763
[25] Model of the HIV-1 integrase-viral DNA complex - A template for structure-based design of HIV in inhibitors.
Karki, R
Tang, Y
Nicklaus, MC
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U9 - U10
[26] Development of the next generation of HIV-1 integrase inhibitors: Pyrazolone as a novel inhibitor scaffold
Hadi, Victor
Koh, Yung-Hyo
Sanchez, Tino Wilson
Barrios, Danielle
Neamati, Nouri
Jung, Kyung Woon
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (22) : 6854 - 6857
[27] Multimerization selective inhibitors of HIV-1 integrase
Kvaratskhelia, Mamuka
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
[28] HYDROXYLATED AROMATIC INHIBITORS OF HIV-1 INTEGRASE
BURKE, TR
FESEN, MR
MAZUMDER, A
WANG, J
CAROTHERS, AM
GRUNBERGER, D
DRISCOLL, J
KOHN, K
POMMIER, Y
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (21) : 4171 - 4178
[29] Peptide HIV-1 Integrase Inhibitors from HIV-1 Gene Products
Suzuki, Shintaro
Urano, Emiko
Hashimoto, Chic
Tsutsumi, Hiroshi
Nakahara, Toru
Tanaka, Tomohiro
Nakanishi, Yuta
Maddali, Kasthuraiah
Han, Yan
Hamatake, Makiko
Miyauchi, Kosuke
Pommie, Yves
Beutler, John A.
Sugiura, Wataru
Fuji, Hideyoshi
Hoshino, Tyuji
Itotani, Kyoko
Nomura, Wataru
Narumi, Tetsuo
Yamamoto, Naoki
Komano, Jun A.
Tamamura, Hirokazu
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (14) : 5356 - 5360
[30] Discovery of novel HIV-1 integrase inhibitors
Hong, HX
Neamati, N
Wang, SM
Nicklaus, M
Pommier, Y
Milne, GWA
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 22 - MEDI

← 1 2 3 4 5 →